Skip to content

Evaluation of conditions causing eye discomfort by 222 nm Far-UVC disinfectant lamps

Prospective Intervention Study on Eye Discomfort Caused by 222 nm Far-UVC Disinfectant Lamps - Prospective Intervention Study on Eye Discomfort Caused by 222 nm Far-UVC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054946
Enrollment
36
Registered
2024-07-12
Start date
2024-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye discomfort

Interventions

A commercially available 222 nm Far-UVC disinfection lamp (Care222) or a dummy irradiation device (incorporating an optical LED in place of the 222 nm Far-UVC lamp) is irradiated to the eyes of the st
22 mJ/cm2. The irradiation duration was 3 hours, of which 2 hours were irradiated by the 222 nm Far-UVC disinfection lamp and 1 hour by the dummy irradiation device. A commercially available 222 nm Fa
11 mJ/cm2. The irradiation duration was 3 hours, of which 1 hours were irradiated by the 222 nm Far-UVC disinfection lamp and 2 hours by the dummy irradiation device. A commercially available 222 nm F
11 mJ/cm2. The irradiation duration was 3 hours, all with 222 nm Far-UVC disinfection lamps. A commercially available 222 nm Far-UVC disinfection lamp (Care222) or a dummy irradiation device (incorpor
5.5 mJ/cm2. The irradiation duration was 3 hours, of which 1.5 hours were irradiated by the 222 nm Far-UVC disinfection lamp and 1.5 hours by the dummy irradiation device. A commercially available 222

Sponsors

Shimane Univesity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient must be able to give his/her free and written consent to participate in the study. Must be able to avoid excessive exposure to ultraviolet light (e.g., outdoor sports, swimming, mountain climbing, etc.) at each observation and within 48 hours prior to the time of exposure to ultraviolet light. Visual acuity before enrollment and within 1 week of the scheduled irradiation must meet all of the following conditions Corrected visual acuity of 0.9 or better in each eye Naked eye visual acuity of 0.3 or better with both eyes open (the patient must be able to view images on a monitor during UVC irradiation). The patient must not be undergoing treatment for ocular diseases that affect visual acuity. No use of eye drops or topical facial skin medications

Exclusion criteria

Exclusion criteria: 1) Daily contact lens wearer 2) Intend to wear contact lenses temporarily (e.g., during sports) within 1 week of irradiation. 3) Engaged in an occupation that exposes them to ultraviolet radiation on a daily basis (e.g., working outdoors, welding, etc.) 4) Have obvious ocular disorders (corneal erosion D score > 2 or conjunctival hyperemia score > 2) observed before enrollment and within 1 week of the scheduled irradiation 5) Has dry eye 6) Comorbid atopic dermatitis 7) Sun sensitivity 8) History or family history of hereditary tumors or melanoma 9) Currently participating in another clinical trial involving an intervention or will participate between the date of enrollment in this study and the end date of observation 10) Other patients deemed ineligible by the investigator of this study

Design outcomes

Primary

MeasureTime frame
Eye discomfort reported by participants at 1 hour, 2 hours, 3 hours (immediately after the end of irradiation), 6 hours and 24 hours after the beginning of irradiation with 222 nm Far-UVC (answers based on a questionnaire).

Countries

Japan

Contacts

Public ContactSachiko Kaidzu

Shimane University Faculty of Medicine Department of Ophthalmology

kecha@med.shimane-u.ac.jp0853-20-2284

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026